GOOG Apr 2016 860.000 call
| Previous close | 0.7000 |
| Open | 0.0000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 860.00 |
| Expiry date | 2016-04-29 |
| Day's range | 0.0000 - 0.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 203 |
- Yahoo Finance Video
Consumer sentiment drops, Tesla's Supercharger, Zeekr IPO: Catalysts
The University of Michigan's Consumer Sentiment Index reported that preliminary data for the month of May fell below estimates, a six-month low of 67.4, which could complicate the Federal Reserve's mission to drive inflation down to 2%. Artificial intelligence developer OpenAI is reportedly developing an AI-powered search engine that could rival Alphabet's Google (GOOGL, GOOG), and it could drop as early as Monday, May 13 according to Reuters. Path Trading Partners Co-Founder and Chief Market Strategist Bob Iaccino joins Catalysts to detail how Fed interest rate cuts and asset inflation could fuel a jump in gold futures (GC=F). Gartner Vice President and Team Manager of Automotives, Transportation, and Cross Manufacturing Mike Ramsey also sits down to explain the future of Tesla's (TSLA) Supercharger network and the EV maker's plans for its full self-driving autonomous vehicles down the line. Other notable guests this hour include Santander US CEO Tim Wennes (SAN) and Gen Digital CEO Vincent Pilette (GEN). This post was written by Luke Carberry Mogan.
- Yahoo Finance Video
How to spot the tech unicorn to invest in: Opening Bid
Finding the right investment can sometimes be difficult, while finding a sleeper hit investment that grows into something like Ring can seem impossible. M13 is known for investing in early-stage, disruptive tech companies that revolutionize consumers everyday life. But how can investors at any stage learn how to spot a tech unicorn like Ring? How can investors tell the difference between what's good and what's too good to be true? Yahoo Finance Executive Editor Brian Sozzi is joined by M13 Co-Founder Carter Reum to give insight into finding success in calculated investments, spotting liars in business, AI in the labor force, and much more. For more expert insight and the latest market action, click here This post was written by Nicholas Jacobino
BenzingaFrom Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch
Pharmaceutical companies have been at the forefront of artificial intelligence for quite some time. Researchers have been using advanced AI models to understand disease mechanisms even before the recent surge in interest. Wednesday, researchers at Alphabet Inc’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google DeepMind developed AlphaFold 3, a new artificial intelligence (AI) model. AlphaFold 3 can predict the structure and interactions of biological molecules. This includes proteins, DNA, RNA, and small mol
